TRILEPTAL
- Product NDC
- 61919-569
- 11-digit product format
- 619190569
- Labeler code
- 61919
- Product ID
- 61919-569_33af9350-95f4-384e-e054-00144ff88e88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXCARBAZEPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA077802
- Marketing category
- ANDA
- Marketing start
- 2016-05-25
- Marketing end
- 0000-00-00
- Substance
- OXCARBAZEPINE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-569-30 | TRILEPTAL | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-569 | TRILEPTAL (OXCARBAZEPINE) TABLET [DIRECT RX] | 1 | Legacy NDC, 1 package rows | 20160526_33af9350-95f3-384e-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 61919-569-30 | 61919056930 | 30 in 1 BOTTLE | Historical |